How to Win at the Partnering Game

Biotech companies are increasingly seeing the importance of aligning with strategic partners to advance their drug  candidates to the market. For the small biotech company, timing and strategy are crucial, but they only matter once you have know how to play game.


Linda Pullan outlines the rules of the partnering game – whether it’s partnering from preclinical to late clinical development – to show you what to expect in moving from introductions to negotiations of a license or acquisition and how to win with a clear strategy.


get THE
WHITEPAPER

WHITEPAPER AUTHOR:

Company team

Linda Pullan, PhD

Pullan Consulting

Linda offers biotech and
pharmaceutical companies consulting
in all aspects of partnering. Linda has
a Ph.D. in Biochemistry, a B.S. in
Chemistry, and more than twenty
years of drug industry
experience. Learn More


SPONSORED BY: